This is randomized double blind clinical trial (phase 2) with placebo that is done in 60 parturient 15 -45 years with ASA class 1&2 candidate for cesarean section under spinal anesthesia. Patients with history of hypertension; hyperthyroidism; convulsion; symptoms of increasing ICP; psychiatric disorders; ischemic heart disease; valvular heart disease; Ketamin allergy; liver & renal failure; alcohol or drugs abuse; spinal anesthesia contraindications(patients refuse, coagulation disorders, local infections, neurologic disorders, severe anemia,...); spinal failure & general anesthesia is excluded. In all patients after receiving 500 ml serum ringer and spinal anesthesia with 12.5 mg Bupivacain 0.5% cesarean section is done. After closure perituine in K group 0.5mg/kg(0.05ml/kg) ketamin and in P group (0.05ml/kg) normal saline subcutaneously is infiltrated.VAS of pain, BP, PR, RR & SPO2 in pre administration of drug , arrival to recovery , 30 minutes after staying in recovery, delivery time of recovery and 2, 4, 6, 8, 12 and 24 hours after surgery by nursing is measured.